This method of maintaining sustained levels of IFN-α has been shown to offer protection to mice when administered up to a week before infection with Western equine encephalitis virus [17] and one day prior to infection with the genetically related Venezuelan equine encephalitis virus [18]. The gene discussed is IFNA1; the disease is infection.